DVHGF (Devonian Health Group) Enterprise Value: $18.67 Mil (As of Jul. 03, 2026) ***


DVHGF Devonian Health Group Inc DVHGF
49 GF Score
Price $7.00
GF Value $3.02
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Devonian Health Group Enterprise Value?

Devonian Health Group DVHGF 49 Enterprise Value is $18.67 Mil as of Jul. 03, 2026. GuruFocus rates DVHGF with a GF Score™ of 49/100 and a GF Value™ of $3.02 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Devonian Health Group's Enterprise Value is $18.67 Mil. Devonian Health Group's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 was $-3.04 Mil. Therefore, Devonian Health Group's EV-to-EBIT ratio for today is -6.14.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Devonian Health Group's Enterprise Value is $18.67 Mil. Devonian Health Group's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was $-2.86 Mil. Therefore, Devonian Health Group's EV-to-EBITDA ratio for today is -6.52.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Devonian Health Group's Enterprise Value is $18.67 Mil. Devonian Health Group's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 was $7.31 Mil. Therefore, Devonian Health Group's EV-to-Revenue ratio for today is 2.56.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Devonian Health Group's Enterprise Value is $18.67 Mil. Devonian Health Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 was $-7.04 Mil. Therefore, Devonian Health Group's EV-to-OCF ratio for today is -2.65.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Devonian Health Group's Enterprise Value is $18.67 Mil. Devonian Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was $-7.04 Mil. Therefore, Devonian Health Group's EV-to-FCF ratio for today is -2.65.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Devonian Health Group  (OTCPK:DVHGF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Devonian Health Group's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=18.667/-3.04
=-6.14

Devonian Health Group's current Enterprise Value is $18.67 Mil.
Devonian Health Group's EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.04 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Devonian Health Group's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=18.667/-2.864
=-6.52

Devonian Health Group's current Enterprise Value is $18.67 Mil.
Devonian Health Group's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.86 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Devonian Health Group's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=18.667/7.306
=2.56

Devonian Health Group's current Enterprise Value is $18.67 Mil.
Devonian Health Group's Revenue for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.31 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Devonian Health Group's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=18.667/-7.036
=-2.65

Devonian Health Group's current Enterprise Value is $18.67 Mil.
Devonian Health Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.04 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Devonian Health Group's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=18.667/-7.036
=-2.65

Devonian Health Group's current Enterprise Value is $18.67 Mil.
Devonian Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Devonian Health Group Enterprise Value Related Terms


Devonian Health Group Enterprise Value Historical Data

* Premium members only.

The historical data trend for Devonian Health Group's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devonian Health Group Enterprise Value Chart

Devonian Health Group Annual Data
Trend Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 29.84 18.16 21.67

Devonian Health Group Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.55 14.42 21.67 7.13 10.98

DVHGF vs VRTX, REGN, ALNY: Enterprise Value Comparison

For the Biotechnology subindustry, Devonian Health Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group Enterprise Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Enterprise Value falls into.


DVHGF
49GF Score
Devonian Health Group Inc DVHGF
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devonian Health Group Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Devonian Health Group's Enterprise Value for the fiscal year that ended in Jul. 2025 is calculated as

Devonian Health Group's Enterprise Value for the quarter that ended in Jan. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $18.67 Mil mean?
Devonian Health Group (DVHGF) has a Enterprise Value of $18.67 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Devonian Health Group and its competitors.
Is Devonian Health Group's Enterprise Value too high?
Devonian Health Group's current Enterprise Value is $18.67 Mil. Overall, Devonian Health Group has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Devonian Health Group's Enterprise Value compare to VRTX and REGN?
Devonian Health Group's Enterprise Value of $18.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Devonian Health Group and its competitors. Devonian Health Group's current Enterprise Value is $18.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devonian Health Group stock overvalued right now?
Based on GuruFocus' analysis, Devonian Health Group (DVHGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.02, compared to a current price of $7.00 — trading 131.8% above its estimated fair value. The current Enterprise Value is $18.67 Mil. Devonian Health Group's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Devonian Health Group (DVHGF), the current Enterprise Value is $18.67 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devonian Health Group (DVHGF) Overvalued in 2026?

Based on GuruFocus' analysis, Devonian Health Group stock appears to be overvalued. The current stock price of $7.00 is trading 131.8% above its estimated GF Value™ of $3.02. GuruFocus considers Devonian Health Group to be Significantly Overvalued.

Key valuation signals for DVHGF:

  • Enterprise Value: $18.67 Mil
  • GF Value™: $3.02 vs. price of $7.00 (131.8% above fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the DVHGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Devonian Health Group Business Description

Other Exchanges GSD:Canada
Address 360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
49GF Score

Get the complete analysis for DVHGF

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.00
Price
$3.02
GF Value